Tradestie Institutional Equity Comparison Engine · Market Close Nov 16, 2026

CGNX vs IPGP: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

CGNX Wins Head-to-Head Institutional Verdict (6–0 across 6 Pillars · 9–1 Matrix Metrics)

CGNX Overall Winner 6-Pillar Tally: CGNX 6 – 0 IPGP Matrix Metrics: CGNX 9 – 1 IPGP

As of Nov 16, 2026, Cognex Corp (CGNX) is the stronger overall head-to-head candidate over IPG Photonics Corporation (IPGP) in the Tradestie Institutional Equity Comparison Engine, winning 9–1 core matrix metrics and 6–0 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). CGNX carries a Unified Composite Score of 59.5/100 (HOLD) at $48.06 (24.7x Forward P/E, 25.0% operating margin), whereas IPGP carries 43.3/100 (HOLD) at $64.47 (29.0x Forward P/E, 5.1% operating margin).

  • Technical & Structure Timing Caution: CGNX is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average and Breakdown options structure phase (RSI 35.9); meanwhile IPGP is in a short-term Weinstein Markdown pullback below its falling 50-day moving average and Breakdown options structure phase (RSI 38.8). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About CGNX vs IPGP
CGNX NASDAQ Head-to-Head Winner
Cognex Corp
Industrial Instruments For Measurement, Display, And Control
$48.06
-3.9% 1D
Market Cap $8.5B
TTM Revenue $1.13B
Forward P/E 24.7x
Beta / 30D Vol 2.19β · 65% Vol
Unified Composite Score
59.5 / 100 HOLD
Tech 45.0 Fund 54.0 Flow 58.0 Mom 60.0
Weinstein Technical Phase Markdown · Sell / avoid
Price below a falling SMA50 (slope -5.1%), weak momentum, RSI 36
RSI-14: 35.9 · SMA20: $53.86 · SMA50: $57.80
IPGP NASDAQ
IPG Photonics Corporation
Semiconductors & Related Devices
$64.47
-4.89% 1D
Market Cap $3.0B
TTM Revenue $1.11B
Forward P/E 29.0x
Beta / 30D Vol 2.47β · 69% Vol
Unified Composite Score
43.3 / 100 HOLD
Tech 40.0 Fund 51.0 Flow 68.0 Mom 64.0
Weinstein Technical Phase Markdown · Sell / avoid
Price below a falling SMA50 (slope -4.0%), weak momentum, RSI 39
RSI-14: 38.8 · SMA20: $70.88 · SMA50: $75.06

6-Pillar Scorecard Institutional Category Breakdown (CGNX 6 – 0 IPGP)

Columns: Metric · CGNX · IPGP
1. Valuation Multiples CGNX
Forward P/E 24.7x 29.0x
Trailing P/E 35.5x 75.4x
PEG Ratio 2.71x 1.83x
EV / Revenue 7.0x 2.1x
2. Growth & Scale CGNX
Revenue Growth (YoY) +13.2% +14.6%
Earnings Growth (YoY) +400.0% +165.8%
TTM Revenue (USD) $1.13B $1.11B
Market Cap $8.5B $3.0B
3. Profitability & Quality CGNX
Gross Margin 69.7% 38.7%
Operating Margin 25.0% 5.1%
Net Profit Margin 21.5% 3.6%
Return on Equity (ROE) 15.1% 1.9%
4. Balance Sheet & Cash Flow CGNX
Cash Generation (TTM) $286M $35M
Cash Flow Margin 25.4% 3.2%
Net Cash / Leverage $624M Net Cash $694M Net Cash
Dividend Yield 0.66% None (0.00%)
5. Options & Positioning CGNX
Options Structure Phase BREAKDOWN BREAKDOWN
Current IV / %ile 53.5% (16th %ile) 70.3% (8th %ile)
Put/Call OI Skew 1.96x (Put-Skewed) N/A
OBV Trend / Tech Phase ACCUMULATION · Markdown NEUTRAL · Markdown
6. R&D & Supply-Chain Moat CGNX
OpEx & R&D Intensity 44.7% of Rev ($503M) 33.6% of Rev ($372M)
90D R&D Disclosures 0 papers 0 papers
Competitive Moat Scale & Operating Efficiency Moat Cyclical / Execution-Driven Positioning
Supply-Chain Role Scientific & Technical Instruments Operator Semiconductor Equipment & Materials Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: CGNX (9) vs IPGP (1)
Institutional Metric CGNX IPGP Criterion Row Edge
Market Capitalization
Scale
$8.5B $3.0B Larger Scale CGNX
Trailing P/E Ratio
Valuation
35.5x 75.4x Lower Multiple CGNX
Forward P/E Ratio
Valuation
24.7x 29.0x Lower Multiple CGNX
Revenue Growth (YoY)
Growth
+13.2% +14.6% Higher Growth IPGP
Operating Margin (TTM)
Profitability
25.0% 5.1% Higher Margin CGNX
Net Profit Margin
Profitability
21.5% 3.6% Higher Margin CGNX
Return on Equity (ROE)
Capital Efficiency
15.1% 1.9% Higher ROE CGNX
52-Week Range Position
Momentum
35% ($35–$73) 3% ($62–$156) Stronger Trend CGNX
Beta / 30D Volatility
Risk Regime
2.19β · 65% Vol 2.47β · 69% Vol Lower Realized Risk CGNX
Unified Institutional Score
Composite Signal
59.5 / 100 (HOLD) 43.3 / 100 (HOLD) Higher Composite CGNX
Trailing 12M Revenue (USD)
Operating Scale
$1.13B $1.11B FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
69.7% 38.7% Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
2.71x PEG · 7.0x EV/Rev 1.83x PEG · 2.1x EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
$286M ($624M Net Cash) $35M ($694M Net Cash) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon IPGP +1.76 pp
CGNX: -10.98% · IPGP: -9.22%
3M Horizon IPGP +3.49 pp
CGNX: -24.21% · IPGP: -20.72%
6M Horizon CGNX +17.01 pp
CGNX: -22.37% · IPGP: -39.38%
1Y Horizon CGNX +50.79 pp
CGNX: +29.72% · IPGP: -21.07%

Financial Trajectory Multi-Year Annual Revenue & Operating Margin Trajectory (USD)

Split-Invariant USD Revenue & Operating Margin (%)
Period CGNX Revenue IPGP Revenue CGNX Op. Margin IPGP Op. Margin Margin Leader
FY2018 $810M $1.46B 27.4% 35.9% IPGP
FY2019 $730M $1.31B 19.7% 17.8% CGNX
FY2020 $810M $1.20B 21.0% 16.5% CGNX
FY2021 $1.04B $1.46B 30.4% 25.2% CGNX
FY2022 $1.01B $1.43B 24.5% 11.9% CGNX
FY2023 $840M $1.29B 15.6% 18.0% IPGP
FY2024 $910M $980M 12.6% -21.3% CGNX
FY2025 $990M $1.00B 16.3% 1.3% CGNX

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
CGNX BREAKDOWN
120d in phase · OBV ACCUMULATION
Current IV 53.5%
IV Percentile 16th %ile
Put/Call OI Skew 1.96x (Put-Skewed)
IV Regime Compressed (<25th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow ACCUMULATION
Exact CGNX Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
IPGP BREAKDOWN
113d in phase · OBV NEUTRAL
Current IV 70.3%
IV Percentile 8th %ile
Put/Call OI Skew N/A
IV Regime Compressed (<25th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal BULLISH
OBV Flow NEUTRAL
Exact IPGP Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
CGNX Moat Profile Scale & Operating Efficiency Moat
Scientific & Technical Instruments Operator
Competes within the Scientific & Technical Instruments value chain with $8.5B market capitalization and 25.0% operating margin.
OpEx & R&D Reinvestment 44.7% of Rev ($503M)
90D Engineering Disclosures 0 Published
IPGP Moat Profile Cyclical / Execution-Driven Positioning
Semiconductor Equipment & Materials Operator
Competes within the Semiconductor Equipment & Materials value chain with $3.0B market capitalization and 5.1% operating margin.
OpEx & R&D Reinvestment 33.6% of Rev ($372M)
90D Engineering Disclosures 0 Published
Mapped Supply-Chain Ecosystem (16 partners):
Corning nLight Lumentum Keysight Technologies

Investor FAQ CGNX vs IPGP Key Questions & Quantitative Answers

As of Nov 16, 2026, Cognex Corp (CGNX) is the stronger overall head-to-head candidate over IPG Photonics Corporation (IPGP) in the Tradestie Institutional Equity Comparison Engine, winning 9–1 core matrix metrics and 6–0 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). CGNX carries a Unified Composite Score of 59.5/100 (HOLD) at $48.06 (24.7x Forward P/E, 25.0% operating margin), whereas IPGP carries 43.3/100 (HOLD) at $64.47 (29.0x Forward P/E, 5.1% operating margin). Technical & Structure Timing Caution: CGNX is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average and Breakdown options structure phase (RSI 35.9); meanwhile IPGP is in a short-term Weinstein Markdown pullback below its falling 50-day moving average and Breakdown options structure phase (RSI 38.8). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

CGNX leads the Growth & Scale pillar: CGNX posts +13.2% YoY revenue growth and +400.0% YoY earnings growth on $1.13B TTM revenue (69.7% gross margin, 25.0% operating margin), compared with IPGP at +14.6% YoY revenue growth and +165.8% YoY earnings growth on $1.11B TTM revenue (38.7% gross margin, 5.1% operating margin). Across the 8-period historical trajectory (FY2018 to FY2025), CGNX cumulative revenue shifted +22.2% while IPGP shifted -31.5%. In operating R&D and SG&A reinvestment, CGNX deploys 44.7% of Rev ($503M) (0 90-day corporate R&D disclosures) versus 33.6% of Rev ($372M) (0 disclosures) for IPGP.

CGNX screens cheaper on headline valuation multiples. CGNX trades at 24.7x Forward P/E, 35.5x Trailing P/E, 2.71x PEG, and 7.0x EV/Revenue (25.4% FCF margin), whereas IPGP trades at 29.0x Forward P/E, 75.4x Trailing P/E, 1.83x PEG, and 2.1x EV/Revenue (3.2% FCF margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against CGNX (15.1% ROE) versus IPGP (1.9% ROE) capital efficiency.

In options market volatility and institutional positioning, CGNX carries 53.5% implied volatility (16th %ile, Compressed (<25th %ile)), a 1.96x (Put-Skewed) Put/Call open-interest ratio, ACCUMULATION on-balance volume, and sits in a BREAKDOWN options structure phase (2.19β · 65% Vol realized risk). By comparison, IPGP carries 70.3% implied volatility (8th %ile, Compressed (<25th %ile)), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in a BREAKDOWN options structure phase (2.47β · 69% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 16, 2026. For educational research only; not investment advice.